Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
Number of shares outstanding for Celltrion
(068270.KS)
Number of shares outstanding as of April 2024 : 141,957,131
According to Celltrion
's latest financial reports and stock price the company's current number of shares outstanding is 141,957,131.
At the end of 2023 the company had 141,957,131 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Celltrion
from 2023 to 2023